-
Providing More Information Can Help Avoid Serious Adverse Drug Reactions (Part of Series: ADRs in US)
Part Four: Doctors Should Be Educating Patients About Compliance With Their Medication Regimen So far in this series we have looked at the extent of serious adverse drug reactions (ADRs) in the U.S. and…
-
Some Recommendations To Reduce Serious Adverse Drug Reactions In The U.S. (Part of Series: ADRs in US)
Part Three: Medication Errors Can Be Reduced By Better Prescribing Methods In our first part of this series, we looked at the extent of serious adverse drug reactions (ADRs) in the U.S., and in…
-
Preventing Serious Adverse Drug Reactions In The U.S. (Part of Series: ADRs in US)
Part Two: FDA-MIT Database Project Should Improve Drug-safety Monitoring In our first part to this series, we took a look at the extent of serious adverse drug reactions (ADRs) in the U.S. In this…
-
Extent Of Serious Adverse Drug Reactions In The U.S. (Part of Series: ADRs in US)
Part One: An Introduction To This All Too Common Problem The World Health Organization defines adverse drug reactions (ADRs), also known as adverse drug events (ADEs), in this manner: A response to a drug…
-
Some Antibiotics Linked To Tendon Rupture; Public Citizen Petitions FDA For Stronger Warnings
Targets Fluoroquinolone Class of Antibiotics: Tequin, Levaquin, Cipro, et al. ____________________________________________________________________ UPDATE: For recent developments regarding personal injury lawsuits that involve Levaquin and tendon-related side effects, visit the Levaquin Information page over at our Drug…
-
FDA Approves New, Stronger Warnings For ADHD Drugs
Sudden Deaths, Strokes, And Heart Attacks In Adults At Usual Doses Several drugs to treat attention deficit hyperactivity disorder (ADHD) — including GlaxoSmithKline (GSK) Plc’s Dexedrine, Novartis AG’s Ritalin, Johnson & Johnson’s Concerta, and…
